IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,874,000 | -45.4% | 407,363 | -49.1% | 0.01% | -50.0% |
| Q4 2018 | $7,089,000 | -56.7% | 800,964 | -44.9% | 0.01% | 0.0% |
| Q3 2018 | $16,358,000 | +124.4% | 1,454,086 | +155.3% | 0.01% | +11.1% |
| Q2 2018 | $7,291,000 | -20.6% | 569,616 | +4.9% | 0.01% | -25.0% |
| Q1 2018 | $9,181,000 | +607.9% | 543,235 | +235.0% | 0.01% | +500.0% |
| Q4 2017 | $1,297,000 | +13.9% | 162,165 | +10.3% | 0.00% | 0.0% |
| Q3 2017 | $1,139,000 | +5.8% | 147,022 | +0.3% | 0.00% | 0.0% |
| Q2 2017 | $1,077,000 | – | 146,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |